查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1736741

全球不孕症检测设备市场规模（按产品类型、应用、最终用户、区域范围和预测）

Global Fertility Testing Devices Market Size By Product Type, By Application, By End-User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

不孕不育检测设备市场规模及预测

2024 年不孕症检测设备市场规模为 5.1669 亿美元，预计到 2032 年将达到 8.7984 亿美元，预测期内（2026-2032 年）的复合年增长率为 6.88%。

推动全球不孕症检测设备市场的因素

不孕症检测设备市场的市场驱动因素可能受到多种因素的影响，其中包括：

不孕症率上升：主要驱动因素是全球不孕症病例的增加。导致不孕症上升的因素包括生育延迟、生活方式改变、环境因素以及潜在的健康问题，这些因素都增加了对不孕症检测设备的需求。

接受度和认知度不断提升：大众对不孕症和生殖健康问题的认识日益加深。随着不孕症检测和治疗方案被广泛接受，越来越多的个人和夫妻积极寻求诊断答案，从而推动市场扩张。

技术发展：随着技术进步，不孕症检测的准确性和可近性不断提高，包括更易于使用、更准确且非侵入性的检测设备的开发。消费者越来越倾向于智慧型手机应用程式、家用检测套组和电子排卵监测器等创新产品。

延后生育趋势：随着越来越多的人因个人、职业或经济原因而推迟生育，不孕症监测和生殖健康也越来越受到重视。老年人和夫妇越来越多地使用不孕症检测设备来确定他们的生殖状况并制定怀孕计划。

其他疾病和卵巢卵巢症候群 (PCOS) 发病率上升：PCOS 和其他影响生育能力的荷尔蒙疾病的流行推动了生育测试设备需求的不断增长。这些疾病需要及早诊断和治疗，以改善生育结果。

家用检测套组的普及：由于家用不孕不育检测套组的实用性和普及性，市场规模显着增长。这些套件越来越受欢迎，因为它们让人们能够轻鬆、谨慎地检查自己的生殖状况。

政府措施和鼓励性医疗保健项目：各国政府和医疗保健机构越来越重视生殖健康，透过提供资金、补贴和支持项目，为不孕症治疗和诊断提供资金支持。这些项目有助于扩大不孕症检测设备的普及。

生育诊所和专家数量的增长：生育诊所和专家数量的增长推动了全球不孕症检测设备市场的发展。这些诊所使用尖端诊断技术频繁地进行不孕症检查，这推动了对此类设备的需求。

医疗支出和可支配收入的增加：尤其是在新兴经济体，可支配收入的增加和医疗成本的上升，使得越来越多的人能够负担得起不孕症检测和治疗费用。这种经济扩张正在推动不孕症检测设备市场的发展。

个人化医疗和医学研究的发展：个人化医疗领域正在不断扩展，其进步有助于创造更先进、更个人化的不孕症检测方案。这些发展提高了不孕症评估的准确性和有效性。

限制全球不孕症检测设备市场的因素

不孕症检测设备市场面临诸多限制与挑战，包括：

昂贵的设备：不孕症检测设备价格不菲，尤其是最尖端科技的型号。高昂的费用可能会限制设备的可及性，尤其是对于没有全额医疗保险或可支配收入较低的地区的人来说。

知识与教育匮乏：大众通常对不孕症相关问题缺乏了解，包括不孕症检测设备的普及程度。这种无知可能导致不孕症检测设备的使用不足。

社会与文化污名：在许多国家，谈论不孕症仍然令人反感。社会对不孕症的污名化可能会阻碍人们接受检测和治疗，从而限制市场扩张。

准确性和可靠性的差异：不孕症检测设备的准确性和可靠性可能存在差异。不孕症检测设备的准确性和可靠性可能存在差异，这可能会导致消费者信心下降，并阻碍不孕症检测设备的广泛使用。高准确性和可靠性对于市场繁荣发展至关重要。

监管挑战：生育测试设备受到严格监管。获得监管部门的批准可能成本高昂且耗时，从而限制了产品的市场准入并延迟了新产品的上市。

缺乏标准化：如果没有既定的测试程序和性能标准，设备性能可能会出现差异。缺乏标准化会造成混乱，并降低客户信心。

保险覆盖和报销问题：保险报销政策差异很大，不孕症相关的检查和治疗并非总是在保险范围内。保险覆盖不足可能会限制不孕症检测设备的使用。

经济因素：消费者在非必需医疗保健产品（例如生育测试设备）上的支出可能会受到经济衰退和经济限制的影响。经济不确定性可能导致消费需求下降。

隐私问题：生育能力测试涉及敏感的个人讯息，对资料安全和隐私的担忧可能会阻止人们使用这些设备，尤其是数位和连网的生育监测器。

技术限制：虽然技术发展推动市场向前发展，但在灵敏度、易用性以及设备与其他健康监测系统的整合方面仍存在限制。为了推动市场成长，必须克服这些技术障碍。

目录

第一章全球不孕症检测设备市场介绍

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章全球不孕症检测设备市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章全球不孕症检测设备市场（按产品）

  • 基础体温（BBT）体温计
  • 排卵预测试剂套件（OPK）
  • 生育监测器
  • 男性不孕检测产品
  • 子宫颈黏液监测仪
  • 荷尔蒙测试
  • 其他的

第六章全球不孕症检测设备市场（按应用）

  • 概述
  • 女性不孕不孕检测
  • 男性不孕症检测

第七章 全球生育测试设备市场（依最终用户）

  • 概述
  • 居家医疗
  • 医院
  • 不孕不育诊所
  • 诊断中心

第八章全球不孕症检测设备市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 其他的
    • 拉丁美洲
    • 中东和非洲

第九章全球不孕症侦测设备市场的竞争格局

  • 概述
  • 各公司市场排名
  • 重点发展策略

第十章 公司简介

  • HiLin Life Products Inc.
  • Prestige Brands Holdings Inc.
  • Quidel Corporation
  • Swiss Precision Diagnostics GmbH
  • Advacare Pharma.
  • Babystart.
  • Church & Dwight Co. Inc.
  • Proov Predict and Confirm.
  • Fertility Focus Limited.
  • Modern Fertility Ovulation.

第十一章 公司简介 附录

  • 相关调查
简介目录
Product Code: 40538

Fertility Testing Devices Market Size And Forecast

Fertility Testing Devices Market size was valued at USD 516.69 Million in 2024 and is projected to reach USD 879.84 Million by 2032, growing at a CAGR of 6.88% during the forecast period 2026-2032.

Global Fertility Testing Devices Market Drivers

The market drivers for the Fertility Testing Devices Market can be influenced by various factors. These may include:

Growing Infertility Rates: A major contributing factor is the growing incidence of infertility globally. The need for fertility testing equipment is increased by variables that lead to rising infertility rates, including delayed childbirth, changes in lifestyle, environmental factors, and underlying health issues.

Growing Acceptance and Awareness: The general public is becoming more conscious of concerns related to fertility and reproductive health. As fertility testing and treatment choices become more widely accepted, more people and couples are motivated to look for diagnostic answers, which propels market expansion.

Technological Developments: The accuracy and ease of fertility testing are continually improved by developments in technology, such as the creation of more user-friendly, accurate, and non-invasive testing instruments. Consumers are drawn to innovations like smartphone applications, home testing kits, and digital ovulation monitors.

Trends in Delayed Parenthood: As more people put off having children for personal, professional, or financial reasons, there is a greater emphasis on fertility monitoring and reproductive health. Fertility testing devices are more commonly used by older persons and couples to determine their reproductive status and schedule pregnancies.

Rise in Other Disorders and Polycystic Ovary Syndrome (PCOS): The increased need for fertility testing equipment is driven by the prevalence of PCOS and other hormone disorders that impact fertility. To improve the outcomes of reproduction, these diseases must be diagnosed and treated early.

Accessibility of Home Testing Kits: The market has grown considerably as a result of the practicality and accessibility of home fertility testing kits. These kits are becoming more and more popular because they make it easy and confidential for people to check their reproductive status.

Encouraging Government Initiatives and Healthcare Policies: With funding, subsidies, and supporting policies for fertility treatments and diagnostics, governments and healthcare organisations are putting more and more emphasis on reproductive health. These programmes aid in expanding the availability of fertility testing equipment.

Growing Number of Fertility Clinics and Specialists: The global fertility testing device market is being driven by the increasing number of fertility clinics and specialists. The need for such gadgets is driven by the fact that these clinics frequently check fertility using cutting-edge diagnostic technologies.

Increasing Spending on Healthcare and Disposable Income: More people are able to afford fertility tests and treatments thanks to rising disposable incomes and rising healthcare costs, especially in emerging nations. This expansion of the economy helps the market for fertility testing equipment.

Developments in Personalised Medicine and Medical Research: The field of personalised medicine is expanding, and its advancements help to create more advanced and individualised fertility testing options. These developments improve the precision and effectiveness of fertility evaluations.

Global Fertility Testing Devices Market Restraints

Several factors can act as restraints or challenges for the Fertility Testing Devices Market. These may include:

Expensive Devices: Fertility testing equipment can be costly, particularly when it comes to models that use cutting-edge technologies. Exorbitant expenses may restrict accessibility, especially for those without full health insurance or in areas with less discretionary income.

Limited Knowledge and Education: The general public frequently has little knowledge and comprehension of fertility-related issues, including the availability of fertility testing equipment. Underuse of these devices may result from this ignorance.

Social and Cultural Stigma: Talking about fertility problems is still frowned upon in many countries. The stigma attached to infertility in society can deter people from getting tested and treated, which would restrict market expansion.

Variability in Accuracy and Reliability: Fertility testing equipment's accuracy and dependability might change. The adoption of these gadgets can be hampered by inconsistent outcomes, which can erode consumer confidence. For the market to flourish, great precision and dependability are essential.

Regulatory Difficulties: Strict regulations apply to fertility testing equipment. Getting regulatory approval can be an expensive and time-consuming procedure that can limit market entry and postpone the release of new products.

Lack of Standardisation: Device performance may vary if there are no established testing procedures or performance standards. Confusion and a decline in customer confidence may result from this lack of standardisation.

Problems with Insurance Coverage and Reimbursement: Policies regarding insurance reimbursement might differ greatly, and tests and treatments related to fertility are not always covered by them. Insufficient insurance coverage may limit the availability of fertility testing equipment.

Economic Factors: Consumer expenditure on non-essential healthcare products, such as fertility testing equipment, can be impacted by economic downturns and financial restraints. Instability in the economy might lower consumer demand.

Privacy Concerns: Sensitive personal health data is involved in fertility testing. People may be discouraged from utilising these devices due to worries about data security and privacy, especially when it comes to digital or connected fertility monitors.

Technological Restrictions: Although technological developments are propelling the market forward, restrictions still exist with regard to the sensitivity, usability, and integration of devices with other health monitoring systems. For the market to grow, these technological obstacles must be overcome.

Global Fertility Testing Devices Market Segmentation Analysis

The Global Fertility Testing Devices Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Fertility Testing Devices Market, By Product Type

  • Ovulation Prediction Kits (OPKs): Devices that detect the surge in luteinizing hormone (LH) to predict ovulation.
  • Fertility Monitors: Advanced devices that track multiple fertility indicators such as basal body temperature (BBT), hormone levels, and cycle length.
  • Male Fertility Testing Kits: Devices used to test sperm count, motility, and overall semen quality.
  • Basal Body Temperature (BBT) Thermometers: Devices used to measure body temperature changes that indicate ovulation.
  • Cervical Mucus Monitors: Devices that assess the consistency of cervical mucus to predict fertility.
  • Hormone-based Tests: Tests that measure hormone levels such as follicle-stimulating hormone (FSH) and estrogen to assess fertility.
  • Others: Including digital fertility trackers, wearable devices, and mobile app-based fertility trackers.

Fertility Testing Devices Market, By Application

  • Female Fertility Testing: Devices specifically designed to assess and monitor fertility in women.
  • Male Fertility Testing: Devices designed to evaluate sperm quality and overall male fertility.

Fertility Testing Devices Market, By End-User

  • Home Care Settings: Individuals and couples using fertility testing devices at home.
  • Hospitals: Medical facilities where fertility testing devices are used as part of fertility assessments and treatments.
  • Fertility Clinics: Specialized clinics focused on diagnosing and treating fertility issues.
  • Diagnostic Centers: Centers that provide comprehensive diagnostic services including fertility testing.

Fertility Testing Devices Market, By Geography

  • North America: Includes the United States and Canada, characterized by high awareness and adoption of fertility testing devices.
  • Europe: Includes countries such as Germany, the UK, France, Italy, and Spain, with strong healthcare systems and a growing focus on fertility health.
  • Asia-Pacific: Includes China, Japan, India, South Korea, and Australia, where increasing healthcare investments and awareness are driving market growth.
  • Latin America: Includes Brazil, Mexico, and other countries in Central and South America, with emerging healthcare markets.
  • Middle East and Africa: Includes countries such as Saudi Arabia, UAE, South Africa, and others, where healthcare infrastructure is expanding and awareness of fertility issues is rising.

Key Players

  • The major players in the Fertility Testing Devices Market are:
  • Church & Dwight Co. Inc.
  • SPD Swiss Precision Diagnostics GmbH
  • AccuQuik
  • Prestige Brands Holdings.Inc.
  • HiLin Life Products.Inc.
  • Fertility Focus Limited
  • Geratherm Medical AG
  • Babystart Ltd
  • Quidel Corporation
  • UEBE Medical GmbH
  • Biozhena Corporation
  • Alere Inc.
  • Taidoc Technology Corporation
  • Fairhaven Health LLC

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FERTILITY TESTING DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL FERTILITY TESTING DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL FERTILITY TESTING DEVICES MARKET, BY PRODUCT

  • 5.1 Basal Body Temperature (BBT) Thermometers
  • 5.2 Ovulation Prediction Kits (OPKs)
  • 5.3 Fertility Monitors
  • 5.4 Male Fertility Testing Products
  • 5.5 Cervical Mucus Monitors:
  • 5.6 Hormone-based Tests
  • 5.7 Others:

6 GLOBAL FERTILITY TESTING DEVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Female Fertility Testing
  • 6.3 Male Fertility Testing

7 GLOBAL FERTILITY TESTING DEVICES MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Home Care Settings
  • 7.3 Hospitals
  • 7.4 Fertility Clinics
  • 7.5 Diagnostic Centers

8 GLOBAL FERTILITY TESTING DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL FERTILITY TESTING DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 HiLin Life Products Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Prestige Brands Holdings Inc.
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Quidel Corporation.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Swiss Precision Diagnostics GmbH.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Advacare Pharma.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Babystart.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Development
  • 10.7 Church & Dwight Co. Inc.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Proov Predict and Confirm.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Fertility Focus Limited.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Development
  • 10.10 Modern Fertility Ovulation.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Development

11 APPENDIX

  • 11.1 Related Research